HealthCare Global Enterprises 将来の成長
Future 基準チェック /46
HealthCare Global Enterprises利益と収益がそれぞれ年間48.2%と14.5%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に14.1% 50.4%なると予測されています。
主要情報
48.2%
収益成長率
50.4%
EPS成長率
| Healthcare 収益成長 | 27.4% |
| 収益成長率 | 14.5% |
| 将来の株主資本利益率 | 14.1% |
| アナリストカバレッジ | Good |
| 最終更新日 | 14 Nov 2024 |
今後の成長に関する最新情報
HealthCare Global Enterprises Limited Just Missed Earnings - But Analysts Have Updated Their Models
Nov 13
HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next
Feb 11Recent updates
HealthCare Global Enterprises Limited Just Missed Earnings - But Analysts Have Updated Their Models
Nov 13We Take A Look At Why HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation Is Well Earned
Sep 19HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next
Feb 11We Think Shareholders Will Probably Be Generous With HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation
Sep 14A Look At The Fair Value Of HealthCare Global Enterprises Limited (NSE:HCG)
Sep 05HealthCare Global Enterprises Limited's (NSE:HCG) Business Is Yet to Catch Up With Its Share Price
May 17Does HealthCare Global Enterprises (NSE:HCG) Have A Healthy Balance Sheet?
Jun 24Shareholders Shouldn’t Be Too Comfortable With HealthCare Global Enterprises' (NSE:HCG) Strong Earnings
Jun 03Is HealthCare Global Enterprises (NSE:HCG) Using Too Much Debt?
Dec 08What Does HealthCare Global Enterprises Limited's (NSE:HCG) Share Price Indicate?
Jun 25Insider Buying: The HealthCare Global Enterprises Limited (NSE:HCG) Executive Chairman Just Bought ₹2.4m Worth Of Shares
Mar 14The HealthCare Global Enterprises (NSE:HCG) Share Price Is Up 51% And Shareholders Are Holding On
Mar 03Here's Why HealthCare Global Enterprises (NSE:HCG) Can Afford Some Debt
Jan 27業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 3/31/2027 | 29,517 | 2,010 | 2,345 | 5,301 | 6 |
| 3/31/2026 | 25,682 | 1,165 | 1,382 | 4,406 | 9 |
| 3/31/2025 | 22,559 | 770 | -809 | 3,524 | 8 |
| 9/30/2024 | 20,436 | 570 | 923 | 3,468 | N/A |
| 6/30/2024 | 19,770 | 526 | N/A | N/A | N/A |
| 3/31/2024 | 19,121 | 482 | 989 | 2,846 | N/A |
| 12/31/2023 | 18,592 | 353 | N/A | N/A | N/A |
| 9/30/2023 | 18,140 | 371 | 922 | 2,197 | N/A |
| 6/30/2023 | 17,471 | 309 | N/A | N/A | N/A |
| 3/31/2023 | 16,944 | 293 | 1,184 | 2,516 | N/A |
| 12/31/2022 | 16,174 | 270 | N/A | N/A | N/A |
| 9/30/2022 | 15,507 | -264 | 1,156 | 2,364 | N/A |
| 6/30/2022 | 14,827 | 694 | N/A | N/A | N/A |
| 3/31/2022 | 13,978 | 537 | 1,489 | 2,201 | N/A |
| 12/31/2021 | 13,312 | -544 | N/A | N/A | N/A |
| 9/30/2021 | 12,472 | -379 | 1,089 | 1,510 | N/A |
| 6/30/2021 | 11,431 | -1,633 | N/A | N/A | N/A |
| 3/31/2021 | 10,134 | -1,935 | 851 | 1,205 | N/A |
| 12/31/2020 | 9,858 | -1,349 | N/A | N/A | N/A |
| 9/30/2020 | 9,897 | -1,284 | 751 | 1,271 | N/A |
| 6/30/2020 | 10,202 | -1,284 | N/A | N/A | N/A |
| 3/31/2020 | 10,956 | -1,067 | 223 | 1,301 | N/A |
| 12/31/2019 | 10,832 | -718 | N/A | N/A | N/A |
| 9/30/2019 | 10,541 | -552 | N/A | N/A | N/A |
| 6/30/2019 | 10,210 | -394 | N/A | N/A | N/A |
| 3/31/2019 | 9,787 | -248 | -903 | 985 | N/A |
| 12/31/2018 | 9,430 | -135 | N/A | N/A | N/A |
| 9/30/2018 | 9,004 | -41 | N/A | N/A | N/A |
| 6/30/2018 | 8,661 | 124 | N/A | N/A | N/A |
| 3/31/2018 | 8,307 | 205 | N/A | 978 | N/A |
| 12/31/2017 | 7,909 | 257 | N/A | N/A | N/A |
| 9/30/2017 | 7,608 | 278 | N/A | N/A | N/A |
| 6/30/2017 | 7,237 | 219 | N/A | N/A | N/A |
| 3/31/2017 | 7,001 | 230 | N/A | 913 | N/A |
| 12/31/2016 | 6,705 | 208 | N/A | N/A | N/A |
| 9/30/2016 | 6,392 | 133 | N/A | N/A | N/A |
| 6/30/2016 | 6,081 | 67 | N/A | N/A | N/A |
| 3/31/2016 | 5,842 | -178 | N/A | 732 | N/A |
| 12/31/2015 | 5,611 | -33 | N/A | N/A | N/A |
| 9/30/2015 | 5,494 | 9 | N/A | 763 | N/A |
| 6/30/2015 | 5,323 | 9 | N/A | N/A | N/A |
| 3/31/2015 | 5,194 | 8 | N/A | 597 | N/A |
| 3/31/2014 | 4,513 | -356 | N/A | 514 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: HCGの予測収益成長率 (年間48.2% ) は 貯蓄率 ( 6.7% ) を上回っています。
収益対市場: HCGの収益 ( 48.2% ) はIndian市場 ( 18% ) よりも速いペースで成長すると予測されています。
高成長収益: HCGの収益は今後 3 年間で 大幅に 増加すると予想されています。
収益対市場: HCGの収益 ( 14.5% ) Indian市場 ( 10.5% ) よりも速いペースで成長すると予測されています。
高い収益成長: HCGの収益 ( 14.5% ) 20%よりも低い成長が予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: HCGの 自己資本利益率 は、3年後には低くなると予測されています ( 14.1 %)。